Guía completa sobre el Cuerpo de Índice de Redondez BRI y su uso clínico

Title: Comprehensive Guide on the Body Roundness Index (BRI) and Its Clinical Use. Authors: He Ye, Chief Nurse at the Chinese Academy of Medical Sciences Hospital in Beijing; Ma Fangfang, Deputy Nursing Director at Peking Union Medical College Hospital; Xia Ying, Deputy Nursing Director at Beijing Alliance Hospital of the Chinese Academy of Medical Sciences. Review: Shen Jianzhong, Associate Physician at Peking Union Medical College Hospital. Production: Popular Science China. The cover image of this article comes from a licensed image library. Reproduction may lead to copyright disputes.

With the worsening of the global obesity epidemic, the limitations of the Body Mass Index (BMI) in assessing metabolic risk are becoming increasingly evident. The BMI cannot differentiate between lean mass (muscles, bones) and fat tissue, nor does it reflect the distribution of fat tissue in the body. The Body Roundness Index (BRI), as a new geometric-based indicator, integrates height and abdominal circumference data to quantify the degree of fat accumulation in the torso, offering a new perspective for evaluating the risk of central obesity and related metabolic diseases. This article aims to analyze in depth the principles behind the BRI construction, compare its advantages and disadvantages with traditional indicators, and explore its clinical value and future applications in cardiovascular metabolic diseases.

Obesity is the main risk factor for type 2 diabetes, cardiovascular diseases, non-alcoholic fatty liver disease, and various types of cancer. However, the traditional BMI-based obesity assessment system has significant limitations. For example, individuals with a developed muscle mass may have vastly different metabolic risks compared to those with excessive fat accumulation at the same BMI level. Additionally, BMI struggles to identify individuals with 'normal weight obesity' (NWO). Consequently, there is an urgent need in both clinical and public health fields to develop an indicator that accurately reflects fat distribution, especially visceral fat accumulation. In this context, the BRI has been proposed and quickly validated.

The construction of the BRI and its biological significance.

The theoretical basis of the BRI derives from elliptical geometry. The human trunk can be approximated as a cylinder, with its cross-sectional area determined by the waist circumference. Through a mathematical formula, the BRI converts the ratio of waist circumference to height into a continuous value, thus objectively describing the body's 'roundness'.

In this context, WC refers to waist circumference (cm) and Height refers to height (cm).

Biological significance: The central value of the BRI lies in its specific ability to reflect abdominal obesity. Abdominal fat, especially visceral fat, is a key driving factor in metabolic disorders. Visceral fat, by releasing free fatty acids and pro-inflammatory cytokines, directly affects insulin sensitivity and accelerates atherosclerosis. The BRI, by measuring waist circumference, indirectly captures the accumulation of visceral fat, making it more representative of the biological basis of metabolic risk compared to BMI.

II. Comparative analysis between BRI and traditional indicators.

For a comprehensive assessment of the effectiveness of the Belt and Road Initiative (BRI), it has been systematically compared with the Body Mass Index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR).

Data from large cohort studies confirm that the area under the curve (AUC) of BRI is significantly higher than that of BMI and WHR in predicting all-cause mortality, cardiovascular events, and the incidence risk of type 2 diabetes.

III. Clinical value of BRI in cardiovascular and metabolic diseases.

1. Prediction of cardiovascular disease (CVD) risk.

Several prospective studies have confirmed that the Body Roundness Index (BRI) is a strong predictor of the incidence and mortality of cardiovascular diseases (CVD).

Mechanism: An increased visceral fat index (BRI) reflects visceral fat accumulation, which may cause vascular endothelial dysfunction, increased oxidative stress, and activation of the inflammatory response, all of which are pathological bases of atherosclerosis.

Clinical evidence: In a meta-analysis that included over 100,000 subjects, for each unit increase in the Body Roundness Index (BRI), the risk of coronary heart disease increases by approximately 12% and the risk of stroke increases by approximately 8%. This correlation is independent of Body Mass Index (BMI), indicating that the BRI provides independent risk information that BMI does not capture.

2. Early detection of type 2 diabetes (T2DM).

BRI shows exceptional performance in the detection of diabetes.

Ø Advantages: Compared to BMI, the BRI reflects insulin resistance more sensitively. Among the 'normal weight but obese' population with a normal BMI but elevated BRI, the probability of developing glucose intolerance and type 2 diabetes is significantly higher than in the general population.

Recommended application: In health centers and primary care institutions, BRI can be used as a complementary screening tool alongside BMI. For those individuals whose BRI is above the critical threshold, an oral glucose tolerance test (OGTT) should be recommended for early detection of diabetes.

3. Assessment of non-alcoholic fatty liver disease (NAFLD).

NAFLD is highly associated with abdominal obesity. The Body Roundness Index (BRI) shows a positive correlation with liver fat content. In situations where measuring liver elasticity is not conveniently feasible, BRI can serve as a simple alternative indicator for evaluating the severity of NAFLD and the risk of fibrosis, being especially useful in resource-limited areas.

IV. Applicable groups and precautions.

1. Recommendations for key high-risk groups.

High-risk group for metabolic syndrome: individuals with a family history of hypertension, dyslipidemia, and hyperglycemia.

Individuals with normal weight but obesity: thin limbs but distended abdomen, normal BMI but perceiving inadequate metabolism.

Menopausal women: the decline in estrogen levels results in fat redistribution towards the abdomen.

Office workers who spend a lot of time sitting and lack exercise.

2. Limitations and prospects.

Despite the remarkable advantages of the Belt and Road Initiative (BRI), it still presents certain limitations:

Population differences: BRI reference values need to be adjusted across different populations according to race, gender, and age groups.

Muscle interference: For professional athletes or individuals who engage in extreme exercise, muscle development may cause the waist to be relatively broader, which could lead to a slight overestimation of the Body Roundness Index (BRI), although this phenomenon has minimal impact on the general clinical population.

Lack of dynamic data: Currently, longitudinal follow-up studies on BRI are still relatively scarce, and its value in monitoring the effects of interventions in diseases needs to be further explored.

V. Conclusion and prospects.

In summary, the Body Roundness Index (BRI) is a simple, economical, and highly sensitive obesity assessment indicator. It compensates for the shortcomings of the traditional BMI, which 'only considers weight without taking into account shape,' and shows great potential for clinical application in predicting the risk of cardiovascular metabolic diseases, early detection, and risk stratification.

In the future, with the development of big data and artificial intelligence, it is expected that the Body Roundness Index (BRI) will combine with wearable devices, such as smart body fat scales, to achieve automated and real-time health risk monitoring. For clinical physicians, integrating BRI into routine check-up reports not only allows for a more comprehensive assessment of patients' health status but also provides more specific guidance for lifestyle interventions, thereby achieving a true transition from 'treating diseases' to 'preventing diseases.'